Show simple item record

dc.contributor.authorHe, Yanpu
dc.contributor.authorHong, Celestine
dc.contributor.authorLi, Jiahe
dc.contributor.authorHoward, MayLin T.
dc.contributor.authorLi, Yingzhong
dc.contributor.authorTurvey, Michelle E.
dc.contributor.authorUppu, Divakara S. S. M.
dc.contributor.authorMartin, John R.
dc.contributor.authorZhang, Ketian
dc.contributor.authorIrvine, Daniel
dc.contributor.authorHammond, Paula T
dc.date.accessioned2020-06-11T19:45:05Z
dc.date.available2020-06-11T19:45:05Z
dc.date.issued2018-10
dc.date.submitted2018-07
dc.identifier.issn1936-0851
dc.identifier.issn1936-086X
dc.identifier.urihttps://hdl.handle.net/1721.1/125770
dc.description.abstractThe utility of layer-by-layer (LbL) coated microneedle (MN) skin patches for transdermal drug delivery has proven to be a promising approach, with advantages over hypodermal injection due to painless and easy self-administration. However, the long epidermal application time required for drug implantation by existing LbL MN strategies (15-90 min) can lead to potential medication noncompliance. Here, we developed a MN platform to shorten the application time in MN therapies based on a synthetic pH-induced charge-invertible polymer poly(2-(diisopropylamino) ethyl methacrylate-b-methacrylic acid) (PDM), requiring only 1 min skin insertion time to implant LbL films in vivo. Following MN-mediated delivery of 0.5 μg model antigen chicken ovalbumin (OVA) in the skin of mice, this system achieved sustained release over 3 days and led to an elevated immune response as demonstrated by significantly higher humoral immunity compared with OVA administration via conventional routes (subcutaneously and intramuscularly). Moreover, in an ex vivo experiment on human skin, we achieved efficient immune activation through MN-delivered LbL films, demonstrated by a rapid uptake of vaccine adjuvants by the antigen presenting cells. These features, rapid administration and the ability to elicit a robust immune response, can potentially enable a broad application of microneedle-based vaccination technologies.en_US
dc.language.isoen
dc.publisherAmerican Chemical Society (ACS)en_US
dc.relation.isversionofhttp://dx.doi.org/10.1021/acsnano.8b05373en_US
dc.rightsArticle is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.en_US
dc.sourceProf. Hammond via Ye Lien_US
dc.titleSynthetic Charge-Invertible Polymer for Rapid and Complete Implantation of Layer-by-Layer Microneedle Drug Films for Enhanced Transdermal Vaccinationen_US
dc.typeArticleen_US
dc.identifier.citationHe, Yanpu et al. "Synthetic Charge-Invertible Polymer for Rapid and Complete Implantation of Layer-by-Layer Microneedle Drug Films for Enhanced Transdermal Vaccination." ACS Nano 12, 10 (October 2018): 10272–10280 © 2018 American Chemical Societyen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Chemical Engineeringen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biological Engineeringen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Materials Science and Engineeringen_US
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MITen_US
dc.relation.journalACS Nanoen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2020-06-08T17:09:07Z
dspace.date.submission2020-06-08T17:09:10Z
mit.journal.volume12en_US
mit.journal.issue10en_US
mit.licensePUBLISHER_POLICY
mit.metadata.statusComplete


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record